Published March 2016 | Version v1
Journal article

The clinical value of CT-guided percutaneous needle biopsy in the diagnosis of pulmonary hilar masses

  • 1. Department of Radiology, Tsinghua Changgeng Hospital, Medical Center of Tsinghua University, Beijing (China)
  • 2. Department of Radiology, Peking University Third Hospital, Beijing (China)
  • 3. Department of Radiology, Peking Union Medical College Hospital, Beijing (China)

Description

Objective: To evaluate CT-guided percutaneous needle biopsy in diagnosing pulmonary hilar masses. Methods: CT-guided percutaneous needle biopsy was performed in 76 patients with pulmonary hilar mass, in whom fiber bronchoscopy examination failed or no definite pathological result was obtained. Results: The positive rate of biopsy in 76 patients was 100%. The pathological diagnoses included squamous cell carcinoma (n = 32), small cell lung cancer (n = 13), adenocarcinoma (n = 27), large cell carcinoma (n = 3) and lymphoma (n = 1). Of the 76 patients, EGFR examination was carried out in 58 and the mutation rate was 46.6% (27/58). Conclusion: CT-guided percutaneous needle biopsy carries higher diagnostic positive rate for pulmonary hilar masses. This technique can provide reliable pathological diagnosis, which is very helpful in guiding clinical treatment. (authors)

Additional details

Publishing Information

Journal Title
Journal of Interventional Radiology
Journal Volume
25
Journal Issue
3
Journal Page Range
p. 231-233
ISSN
1008-794X

INIS

Country of Publication
China
Country of Input or Organization
China
INIS RN
52084016
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BIOPSY; CARCINOMAS; COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; LUNGS; LYMPHOMAS; MUTATIONS; PATIENTS
Descriptors DEC
BODY; DIAGNOSTIC TECHNIQUES; DISEASES; IMMUNE SYSTEM DISEASES; NEOPLASMS; ORGANS; RESPIRATORY SYSTEM; TOMOGRAPHY

Optional Information

Notes
2 figs., 8 refs.; http://dx.doi.org/10.3969/j.issn.1008-794X.2016.03.011